Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Clinical trial NCT06780098 · RECRUITING
Trial details
- NCT number
- NCT06780098
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-28
- Primary completion
- 2032-03-02
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.